- Home
- MTVA vs WKSP Comparison
MTVA vs WKSP Comparison
Compare MTVA & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTVA
- WKSP
- Stock Information
- Founded
- MTVA 2014
- WKSP 2003
- Country
- MTVA United States
- WKSP United States
- Employees
- MTVA N/A
- WKSP N/A
- Industry
- MTVA
- WKSP Auto Parts:O.E.M.
- Sector
- MTVA
- WKSP Consumer Discretionary
- Exchange
- MTVA NYSE
- WKSP Nasdaq
- Market Cap
- MTVA 18.9M
- WKSP 21.3M
- IPO Year
- MTVA N/A
- WKSP N/A
- Fundamental
- Price
- MTVA $1.85
- WKSP $0.95
- Analyst Decision
- MTVA
- WKSP
- Analyst Count
- MTVA 0
- WKSP 0
- Target Price
- MTVA N/A
- WKSP N/A
- AVG Volume (30 Days)
- MTVA 256.5K
- WKSP 2.8M
- Earning Date
- MTVA 11-07-2024
- WKSP 11-13-2024
- Dividend Yield
- MTVA N/A
- WKSP N/A
- EPS Growth
- MTVA N/A
- WKSP N/A
- EPS
- MTVA N/A
- WKSP N/A
- Revenue
- MTVA N/A
- WKSP $6,395,908.00
- Revenue This Year
- MTVA N/A
- WKSP $366.78
- Revenue Next Year
- MTVA N/A
- WKSP $311.43
- P/E Ratio
- MTVA N/A
- WKSP N/A
- Revenue Growth
- MTVA N/A
- WKSP 776.97
- 52 Week Low
- MTVA $1.55
- WKSP $0.36
- 52 Week High
- MTVA $6.75
- WKSP $1.66
- Technical
- Relative Strength Index (RSI)
- MTVA N/A
- WKSP 62.36
- Support Level
- MTVA N/A
- WKSP $0.78
- Resistance Level
- MTVA N/A
- WKSP $1.09
- Average True Range (ATR)
- MTVA 0.00
- WKSP 0.11
- MACD
- MTVA 0.00
- WKSP 0.03
- Stochastic Oscillator
- MTVA 0.00
- WKSP 69.11
About MTVA METAVIA INC
MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers.